VJOncology
VJOncology Podcast
The Video Journal of Oncology (VJOncology) podcast covers the latest solid oncology news from international experts, including breast, lung, skin, genitourinary, head and neck, gynecological and more! Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com
Be sure to visit the podcast's website and support the creator: vjoncology.podbean.com
Author
VJOncology
Category
Podcast website
Latest episode
Nov 13, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
iwCAR-T Sessions: emerging CARs & challenges in solid tumors 17.06.2022 9:49
This year’s International Workshop on CAR-T (iwCAR-T) featured a whole day on the development of CAR T-cell therapies in solid tumors. CAR T-cell therapy has revolutionized the treatment of patients with hematological malignancies however, application in solid tumors has historically seen limited success. In this discussion, Julian Molina, MD from the Mayo Clinic, Rochester, MN, Daniel Abate-Daga...
ASCO 2022 Daily Round-Ups: Day 3 05.06.2022 14:53
Catch up on our highlights from Day 3 of ASCO 2022!
ASCO 2022 Daily Round-Ups: Day 2 04.06.2022 10:59
Catch up on our highlights from Day 2 of ASCO 2022!
ASCO 2022 Daily Round-Ups - Day 1 04.06.2022 4:47
Catch up on our highlights from Day 1 of ASCO 2022!
Updates in radiation oncology from ESTRO 2022 27.05.2022 26:51
This year’s European Society for Radiotherapy and Oncology (ESTRO) annual congress took place in Copenhagen, Denmark, from 6-10 May 2022, and brought together leading experts from across the field of radiation oncology. In this podcast, we focus on some of the significant trial updates presented at the congress. We shall hear from Francesco Cortiula, MD, University Hospital of Udine, Udine, Italy,...
Breast Cancer Sessions: Treatment de-escalation in TNBC 20.05.2022 18:08
The development of complex and effective therapies has improved outcomes in breast cancer, highlighting the need for strategies to escalate and de-escalate treatment. In this exclusive VJSession, Roberto Salgado, MD (GZA Ziekenhuizen Campus Sint-Augustinus, Wilrijk, Belgium) and Marleen Kok, MD (Netherlands Cancer Institute, Amsterdam, Netherlands) discuss the latest advances in triple-negative br...
Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355 16.05.2022 5:03
The European Society for Clinical Oncology (ESMO) Breast Cancer Conference was a hybrid event, held virtually and Berlin, Germany. This renowned meeting brought together global experts who disseminated the latest thinking in breast cancer. VJOncology had the opportunity to speak to Rupert Bartsch, Medical University Vienna, Vienna, Austria, Paolo Tarantino, Dana Farber Cancer Institute, Boston, MA...
Updates in GI cancers from AACR 2022 06.05.2022 8:13
This year’s American Association for Cancer Research (AACR) congress took place in New Orleans, LA, from 8-13 April 2022, and brought together leading experts from across the field of oncology. There were trial updates and presentations of real-world data, as well as discussions on the best ways to improve care for patients. In this podcast, we focus in on gastrointestinal cancers and hear from Mi...
Expanding use of artificial intelligence (AI) in oncology 29.04.2022 10:25
Improvements in early detection, diagnosis, and management have decreased cancer-related mortality, however, challenges associated with personalized care remain. Artificial intelligence (AI) combines computer science and robust datasets to enable problem-solving and has applications within the field of oncology. In this podcast, we hear from Ángel Alberich-Bayarri, PhD, QUIBIM – Quantitative Imag...
The evolving role of nurses amidst global pandemic: perspectives, and highlights from cancer nursing leaders 22.04.2022 13:59
In a world that is still acclimatizing to the COVID-19 pandemic, the fragility of many aspects of our society has been laid bare. Global health care systems were among the most seriously affected by the SARS-CoV-2 which has put a spotlight on the integral role of nurses not only in day-to-day patient care and running of healthcare facilities but also in public education and awareness campaigns, pu...
The GU Cancer Sessions: Prostate & kidney cancer highlights from ASCO GU 2022 11.04.2022 13:34
In this podcast, we hear from genitourinary (GU) cancer experts Tian Zhang, MD, Duke Cancer Center, Durham, NC, and Scott Tagawa, MD, MS, FACP, Weill Cornell Medicine, New York City, NY, as they discuss some of their highlights in prostate and kidney cancer research presented at the 2022 ASCO GU Cancers Symposium, held in San Francisco, CA. Listen to learn about the latest clinical research and pr...
Lung Cancer Screening: Current state and future directions 04.04.2022 20:56
Lung cancer is one of the most common cancers in the world, and has a very low survival rate, partly due to many patients being diagnosed only once their disease has reached an advanced stage. Screening programmes for high-risk populations are a possible solution to this problem, as it would help to identify more lung cancer cases when they are in early stages, and are therefore more treatable. In...
Novel treatment approaches in HR+/HER2- breast cancer 25.03.2022 8:29
Resistance to endocrine therapy in patients with hormone-receptor-positive (HR+), HER2-negative breast cancer inevitably results in relapse and metastasis, leading to death. Understanding mechanisms of intrinsic and acquired resistance have been the focus of many clinical studies. Recent advances including the use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and phosphoinositide 3-kinase (PI...
New treatment approaches for advanced or metastatic urothelial carcinoma 18.03.2022 8:08
Clinical trials presented at the the American Society of Clinical Oncology (ASCO) Genitourinary Cancers (GU) Symposium 2022 have been investigating treatment options for patients with advanced or metastatic UC who are ineligible for or have progressed on platinum-based chemotherapy, in hopes of improving patient prognosis. The LEAP-011 trial explored the addition of the VEGFR inhibitor, lenvatinib...
The Breast Cancer Sessions: Highlights from SABCS 2021 11.03.2022 28:35
The San Antonio Breast Cancer Symposium (SABCS) 2021 saw ground-breaking data and developments in breast cancer being presented and in this special podcast, leading breast cancer experts Hope Rugo (UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA) and Dave Cescon (Princess Margaret Cancer Center, Toronto, Canada), dissect the latest advances in the field and offer their uniq...
The GI Cancer Sessions: Highlights from ASCO GI 2022 04.03.2022 38:10
In this episode of the VJOncology podcast, a panel of leading gastrointestinal (GI) cancer experts offer their perspectives on the key GI cancer data presented at the 2022 ASCO GI Cancers Symposium, held in San Francisco, CA, in January 2022. In this podcast, Nataliya Uboha, MD, PhD, University of Wisconsin, Madison, WI, is joined by Ghassan Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Cent...
Prostate Cancer Highlights from ASCO GU 2022 25.02.2022 13:11
The ASCO Genitourinary (GU) Cancers Symposium took place on the 17-19th February 2022, in San Francisco, CA. Leading experts gave updates on trials in prostate cancer, urothelial carcinoma, renal cell carcinoma, and rare GU cancers, as well as discussing hot topics in the field. In this podcast, we hear from several experts in the field of prostate cancer, as they update us on some of the biggest...
Updates on HER2-positive breast cancer 18.02.2022 7:49
HER2-positive breast cancer accounts for 15-20% of all breast cancer cases. It was associated with a poor prognosis until the approval of trastuzumab, a monoclonal antibody targeting HER2. Since then, the therapeutic landscape for patients with HER2-positive tumors has changed dramatically, with the introduction of other monoclonal antibodies such as pertuzumab, tyrosine kinase inhibitors includin...
BTOG 2022: Highlights in lung cancer 11.02.2022 13:54
For patients with lung cancer, surgical resection is a treatment option and perioperative management is imperative to improve surgical outcomes. Patients undergoing surgery may face a decline in quality of life, especially those who have co-morbidities or are older. Prehabilitation aims to prepare patients mentally and physically before surgery with exercise, nutrition and stress reduction. Whilst...
The multidisciplinary use of ctDNA in gastrointestinal cancers 02.02.2022 11:11
Gastrointestinal (GI) cancer remains one of the leading cause of global cancer mortality. The current standard for diagnosing GI cancers via biopsy is costly and invasive, as well as lacking in reliability. As such, these methods are not used for screening and the majority of GI cancers are diagnosed in the advanced stages of cancer progression, when curative surgery is inadequate and patients mus...
SITC 2021: Updates on the use of cellular therapy in solid tumors 19.01.2022 12:04
Cellular immunotherapy approaches have proven to be highly effective in the treatment of patients with hematological malignancies over recent years. In contrast, the efficacy of cellular immunotherapy in solid tumors has been restricted due to a limited array of tumor-specific antigens to differentiate cancer cells from normal cells. In this podcast, we spoke with three leading experts in cellula...
Breast Cancer Sessions: Highlights from SABCS 2021 with Lisa Carey & Aleix Prat 14.01.2022 16:51
The San Antonio Breast Cancer Symposium 2021 featured exciting developments in early and advanced breast cancer, basic science, and translational research. In this podcast, we had the opportunity to hear from Lisa A. Carey (UNC Lineberger, Chapel Hill, NC) and Aleix Prat (Hospital Clínic Barcelona, Barcelona, Spain) who discuss advances in breast cancer care and management, including highlights fr...
Immunotherapy updates from SABCS 2021 with Heather McArthur & Kevin Kalinsky 04.01.2022 17:41
The success of immunotherapy in the treatment of solid tumors has created hope for its potential in breast cancer. The San Antonio Breast Cancer Symposium 2021 showcased an array of updates in breast cancer care and management, including updates on pivotal trials evaluating the use of immunotherapy in breast cancer. In this podcast, we hear from leading experts, Kevin Kalinsky (Emory University, A...
The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC 25.11.2021 44:45
The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung cancer research. In this podcast, Ross Camidge, MD, PhD, of University of Colorado, Aurora, CO, chairs a lively discussion on the latest advances and standard clinical practices in EGFR-mutated NSCLC, including EGFR testing, options for first-line treatment, and developme...
ISLB 2021: Current standards and future directions for liquid biopsy 12.11.2021 21:32
Liquid biopsy is an exciting field, with many promising advances in recent years. In this podcast, we cover a range of possible uses of liquid biopsy throughout all stages of patient care, from early diagnosis and screening to post-treatment monitoring. We also discuss some of the key challenges that need to be overcome, and think about the future of liquid biopsy research. We are joined by four...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.